The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khruslov M.V.

'Kursk Regional Clinical Hospital' of the Health Committee of Kursk Region, Kursk, Russia

Lobachev V.I.

OOO "Tomograf", Kursk

Ukhanova I.Iu.

OBUZ "Kurskaia gorodskaia klinicheskaia bol'nitsa #4"

Egorcheva Iu.S.

Kurskiĭ gosudarstvennyĭ meditsinskiĭ universitet

The effectiveness of centralized monitoring the international normalized ratio in the patients treated with warfarin after deep venous thrombosis

Authors:

Khruslov M.V., Lobachev V.I., Ukhanova I.Iu., Egorcheva Iu.S.

More about the authors

Journal: Journal of Venous Disorders. 2013;7(4): 52‑56

Read: 1296 times


To cite this article:

Khruslov MV, Lobachev VI, Ukhanova IIu, Egorcheva IuS. The effectiveness of centralized monitoring the international normalized ratio in the patients treated with warfarin after deep venous thrombosis. Journal of Venous Disorders. 2013;7(4):52‑56. (In Russ.)

References:

  1. Rossiyskie klinicheskie rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboembolicheskikh oslozhneniy. M: Media Sfera 2010 [Russian clinical recommendations on diagnostics and treatment of chronic venous diseases]. M: Media Sfera 2010.
  2. Vavilova T.V. Antitromboticheskaya terapiya v klinicheskoy praktike. Printsipy provedeniya i laboratornyy kontrol' (posobie dlya vrachey). SPb: SPbMA 2008  [Anti-thrombotic therapy in the clinical practice. Principles of treatment and laboratory control (guidelines for physicians). SPb: SPbMA 2008].
  3. Hirsch J., Kearon C., Griensberg J. Duration of anticoagulant therapy after first episode of venous thrombosis in patient with inherited thrombophilia. Arch Intern Med 1997; 157: 2174-2177.
  4. Kozlova T.V., Taratuta T.V. Vozmozhnosti optimizatsii antikoagulyantnoy terapii varfarinom [Possibilities for the optimization of. Anticoagulation therapy with the use of varfarin]. Rus med zhurn 2008; 16: 11: 1532-1535.
  5. Jones M., McEwan P., Morgan C.L., Peters J.R., Goodfellow J., Currie C.J. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 2005; 91: 472-477.
  6. Kropacheva E.S. Aktual'nye voprosy terapii varfarinom dlya praktikuyushchikh vrachey [Topical problems of varfarin therapy for general ptsctiioners]. Rus med zhurn 2012; 14: 686-692.
  7. Fitzmaurice D.A., Blan A.D., Lip G.Y.H. Bleeding risk of antithrombotic therapy. BMJ 2002; 325: 828-831.
  8. Levine M., Raskob G., Landefeld C.S., Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 1998; 114: 511-523.
  9. Zateyshchikov D.A., Isaeva M.Yu. Voprosy organizatsii lecheniya antikoagulyantami [The problems of organization of the treatment with anticoagulants]. Klin praktika 2012; 3: 51-62.
  10. Gavrisyuk E.V., Sychev D.A., Ignat'ev I.V., Vydrina N.D., Chikalo A.O., Marinin V.F. Problemy organizatsii terapii nepryamymi antikoagulyantami v ambulatornykh usloviyakh [The problems of organization of the treatment with indirect anticoagulants in an outpatient clinic]. Vestnik Roszdravnadzora 2012; 1: 28-33.
  11. Rosendaal F.R., Cannegieter S.C., van der Meer F.J.M., Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 39: 236-239.
  12. Antitromboticheskaya terapiya pri mertsatel'noy aritmii. Pod red. B.A. Sidorenko. M 2010 [Anti-thrombotic therapy of atrial fibrillation. Ed. V.A. Sidorenko. M.: 2010].
  13. Camm J., Lip G.Y., Raffaele De Caterina. 2012 focused update of the ECS Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of European Heart Rhythm Association. ECS Guidelines 20124; 1-29.
  14. Connoly S.J., Pogue J., Eikelboom J., Flaker G., Commerford P., Franzosi M.G., Healey J.S., Yusuf S. and on the behalf of the ACTIVE W investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 2008; 118: 2029-2037.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.